[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].

Yan Xu, Jiangbin Wang, Jie Xu, Jian Jiao, Yong-gui Zhang, Shang-wei Ji, Ping Zhao, Honghua Guo, Yan Li, Changyu ZhouPubMed 2010 · DOI

Abstract

Entecavir treatment results in suppression of HBV replication and delayed progression of fibrosis in patients with hepatitis B virus-related cirrhosis.
BibTeX
@inproceedings{xu2010antiviral,
  author = {Yan Xu and Jiangbin Wang and Jie Xu and Jian Jiao and Yong-gui Zhang and Shang-wei Ji and Ping Zhao and Honghua Guo and Yan Li and Changyu Zhou},
  title = {{[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].}},
  booktitle = {PubMed},
  year = {2010},
  doi = {10.3760/cma.j.issn.1007-3418.2010.02.008},
}

Loading related content...

Figure